Daehan New Pharm Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Daehan New Pharm Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Daehan New Pharm Co. Ltd (054670) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.43 Billion ≈ $3.00 Million USD) by net assets (₩129.44 Billion ≈ $87.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Daehan New Pharm Co. Ltd (2014–2024)

Cash flow conversion efficiency of Daehan New Pharm Co. Ltd from 2014 to 2024. This chart illustrates how Daehan New Pharm Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 054670 share price today for real-time trading data and today's change.

Daehan New Pharm Co. Ltd Cash Flow Conversion Ratio Explained

Daehan New Pharm Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Daehan New Pharm Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daehan New Pharm Co. Ltd ranked by their cash flow conversion efficiency. Also see Daehan New Pharm Co. Ltd (054670) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Elton International Trading Company S.A AT:ELTON	0.056x
Vertical Aerospace Ltd NYSE:EVTL	2.941x
Viewbix Inc. Common Stock NASDAQ:VBIX	-0.183x
Digihost Technology Inc V:DGHI	-0.819x
Strongpoint ASA OL:STRO	0.061x
Maison Internationale de lInformatique M2I SAS PA:ALMII	0.026x
RS Automation Co.Ltd KQ:140670	0.028x
Vizsla Copper Corp V:VCU	-0.037x

Annual Cash Flow Conversion Efficiency for Daehan New Pharm Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Daehan New Pharm Co. Ltd from 2014 to 2024. Review 054670 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩125.44 Billion ≈ $85.01 Million	₩18.95 Billion ≈ $12.84 Million	0.151x	+31.44%
2023-12-31	₩109.36 Billion ≈ $74.11 Million	₩12.57 Billion ≈ $8.52 Million	0.115x	-16.99%
2022-12-31	₩102.96 Billion ≈ $69.77 Million	₩14.25 Billion ≈ $9.66 Million	0.138x	-31.16%
2021-12-31	₩82.47 Billion ≈ $55.89 Million	₩16.58 Billion ≈ $11.24 Million	0.201x	-15.19%
2020-12-31	₩57.13 Billion ≈ $38.72 Million	₩13.55 Billion ≈ $9.18 Million	0.237x	-36.75%
2019-12-31	₩61.07 Billion ≈ $41.38 Million	₩22.89 Billion ≈ $15.51 Million	0.375x	-21.12%
2018-12-31	₩43.08 Billion ≈ $29.19 Million	₩20.47 Billion ≈ $13.87 Million	0.475x	+1113.94%
2017-12-31	₩51.72 Billion ≈ $35.05 Million	₩-2.42 Billion ≈ $-1.64 Million	-0.047x	-138.14%
2016-12-31	₩71.20 Billion ≈ $48.25 Million	₩8.75 Billion ≈ $5.93 Million	0.123x	+21.58%
2015-12-31	₩77.20 Billion ≈ $52.32 Million	₩7.80 Billion ≈ $5.29 Million	0.101x	-25.43%
2014-12-31	₩73.89 Billion ≈ $50.07 Million	₩10.02 Billion ≈ $6.79 Million	0.136x	--

About Daehan New Pharm Co. Ltd

KQ:054670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$48.51 Million

₩71.58 Billion KRW

Market Cap Rank

#21828 Global

#1325 in Korea

Share Price

₩5100.00

Change (1 day)

-0.58%

52-Week Range

₩5090.00 - ₩7510.00

All Time High

₩21012.38